Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2025-12-25 @ 11:28 PM
Study NCT ID:
NCT01935193
Status:
UNKNOWN
Last Update Posted:
2013-09-05
First Post:
2013-08-28
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Aspirin Resistance Reversibility in Diabetic Patients
Sponsor:
Azienda Ospedaliera San Giovanni Battista
Organization:
Study Overview
Official Title:
Impact of Different Pharmacological Formulations on Aspirin Resistance Reversibility in Diabetics Patients
Status:
UNKNOWN
Status Verified Date:
2013-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ARRDM
Brief Summary:
The aim of the study is assessing the prevalence of aspirin resistance in a cohort of diabetic patients. Those found resistant has been undergone pharmacological tests using different drug formulations to investigate the reversibility of aspirin resistance.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: